Fetal obesity syndrome: Maternal nutrition as a cause of nonalcoholic steatohepatitis

Hepatology

Volumn 50, Issue 6, 2009, Pages 1696-1698

  Charlton, Michael ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOTRANSFERASE; CATHEPSIN B;

AMINOTRANSFERASE BLOOD LEVEL; BODY MASS; DISORDERS OF MITOCHONDRIAL FUNCTIONS; EDITORIAL; FETAL OBESITY SYNDROME; FETUS DISEASE; GENETIC PREDISPOSITION; HUMAN; LIPID PEROXIDATION; LIVER FIBROSIS; MATERNAL BEHAVIOR; MATERNAL NUTRITION; METABOLIC SYNDROME X; NONALCOHOLIC FATTY LIVER; NONHUMAN; OBESITY; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PREGNANCY; PREVALENCE; PRIORITY JOURNAL; RESPIRATORY CHAIN;

ANIMALS; DIETARY FATS; FATTY LIVER; FEMALE; HUMANS; LIPASE; MATERNAL NUTRITIONAL PHYSIOLOGICAL PHENOMENA; MEMBRANE PROTEINS; MICE; OBESITY; PREGNANCY;

EID: 73149092357     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.23371     Document Type: Editorial

References (25)

1. Ogden CL, Carroll MD, Curtin LR, McDowell MA, Tabak CJ, Flegal KM. Prevalence of overweight and obesity in the United States, 1999-2004. JAMA 2006;295:1549-1555.
2. Sturm R. Increases in clinically severe obesity in the United States, 1986-2000. Arch Intern Med 2003;163:2146-2148.
3. Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature 2001;414:813-820.
4. Tilg H, Hotamisligil GS. Nonalcoholic fatty liver disease: cytokine-adipokine interplay and regulation of insulin resistance. Gastroenterology 2006; 131:934-945.
5. Feldstein AE, Canbay A, Angulo P, Taniai M, Burgart LJ, Lindor KD, et al. Hepatocyte apoptosis and fas expression are prominent features of human nonalcoholic steatohepatitis. Gastroenterology 2003;125:437-443.
6. Li Z, Berk M, McIntyre TM, Gores GJ, Feldstein AE. The lysosomalmitochondrial axis in free fatty acid-induced hepatic lipotoxicity. HEPATOLOGY 2008;47:1495-1503.
7. Crespo J, Cayon A, Fernandez-Gil P, Hernandez-Guerra M, Mayorga M, Dominguez-Diez A, et al. Gene expression of tumor necrosis factor alpha and TNF-receptors, p55 and p75, in nonalcoholic steatohepatitis patients. HEPATOLOGY 2001;34:1158-1163.
8. Feldstein AE, Canbay A, Angulo P, Taniai M, Burgart LJ, Lindor KD, et al. Hepatocyte apoptosis and fas expression are prominent features of human nonalcoholic steatohepatitis. Gastroenterology 2003;125:437-443.
9. Poli G. Pathogenesis of liver fibrosis: role of oxidative stress. Mol Aspects Med 2000;21:49-98.
10. Romeo S, Kozlitina J, Xing C, Pertsemlidis A, Cox D, Pennacchio LA, et al. Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease. Nat Genet 2008;40:1461-1465.
11. Jenkins CM, Mancuso DJ, Yan W, Sims HF, Gibson B, Gross RW. Identification, cloning, expression, and purification of three novel human calcium-independent phospholipase A2 family members possessing triacylglycerol lipase and acylglycerol transacylase activities. J Biol Chem 2004;279:48968-48975.
12. Johansson LE, Hoffstedt J, Parikh H, Carlsson E, Wabitsch M, Bondeson AG, et al. Variation in the adiponutrin gene influences its expression and associates with obesity. Diabetes 2006;55:826-833.
13. Liu YM, Moldes M, Bastard JP, Bruckert E, Viguerie N, Hainque B, et al. Adiponutrin: a new gene regulated by energy balance in human adipose tissue. J Clin Endocrinol Metab 2004;89:2684-2689.
14. Kotronen A, Johansson LE, Johansson LM, Roos C, Westerbacka J, Hamsten A, et al. A common variant in PNPLA3, which encodes adiponutrin, is associated with liver fat content in humans. Diabetologia 2009;52:1056-1060.
15. Bruce KD, Cagampang FR, Argenton M, Zhang J, Ethirajan PL, Burdge GC, et al. Maternal high-fat feeding primes steatohepatitis in adult mice offspring, involving mitochondrial dysfunction and altered lipogenesis gene expression. HEPATOLOGY 2009;50:1796-1808.
16. Forsen T, Eriksson JG, Tuomilehto J, Osmond C, Barker DJ. Growth in utero and during childhood among women who develop coronary heart disease: longitudinal study. BMJ 1999;319:1403-1407.
17. Forsen T, Eriksson JG, Tuomilehto J, Teramo K, Osmond C, Barker DJ. Mother's weight in pregnancy and coronary heart disease in a cohort of Finnish men: follow up study. BMJ 1997;315:837-840.
18. Patel MS, Srinivasan M. Metabolic programming: causes and consequences. J Biol Chem 2002;277:1629-1632.
19. Patel MS, Srinivasan M, Aalinkeel R. Metabolic programming by nutrition during early development. Indian J Exp Biol 2000;38:849-855.
20. Patel MS, Srinivasan M, Laychock SG. Metabolic programming: role of nutrition in the immediate postnatal life. J Inherit Metab Dis 2009;32: 218-228.
21. Patel MS, Srinivasan M, Laychock SG. Nutrient-induced maternal hyperinsulinemia and metabolic programming in the progeny. Nestle Nutr Workshop Ser Pediatr Program 2005;55:137-147; discussion 147-151.
22. Misra A, Pandey RM, Devi JR, Sharma R, Vikram NK, Khanna N. High prevalence of diabetes, obesity and dyslipidaemia in urban slum population in northern India. Int J Obes Relat Metab Disord 2001;25:1722-1729.
23. Misra A, Vikram NK, Arya S, Pandey RM, Dhingra V, Chatterjee A, et al. High prevalence of insulin resistance in postpubertal Asian Indian children is associated with adverse truncal body fat patterning, abdominal adiposity and excess body fat. Int J Obes Relat Metab Disord 2004;28:1217-1226.
24. Mitrani P, Srinivasan M, Dodds C, Patel MS. Autonomic involvement in the permanent metabolic programming of hyperinsulinemia in the highcarbohydrate rat model. Am J Physiol Endocrinol Metab 2007;292: E1364-E1377.
25. Grun F, Blumberg B. Environmental obesogens: organotins and endocrine disruption via nuclear receptor signaling. Endocrinology 2006;147:S50-S55.